Nuvalent (NUVL) Change in Acquisitions & Divestments (2022 - 2026)
Nuvalent (NUVL) posted Change in Acquisitions & Divestments of $181.5 million for Q1 2026, up 11.31% on a QoQ basis from $163.1 million in Q4 2025, and down 40.0% year-over-year from $302.6 million in Q1 2025.
Nuvalent (NUVL) Change in Acquisitions & Divestments (2022 - 2026) Analysis & Trends
Nuvalent's Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $181.5 million for Q1 2026.
- Quarterly Change in Acquisitions & Divestments fell 40.0% year-over-year to $181.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $812.6 million (up 19.9% YoY) and the FY2025 annual result came in at $933.7 million, up 106.82% from the prior year.
- Change in Acquisitions & Divestments was $181.5 million for Q1 2026 at Nuvalent, up from $163.1 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $302.6 million in Q1 2025 and bottomed at $27.0 million in Q1 2022.
- A 5-year average of $122.6 million and a median of $105.0 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments soared 296.85% — and 2026, when it sank 40.0%.
- Nuvalent's Change in Acquisitions & Divestments stood at $97.2 million in 2022, then increased by 13.62% to $110.5 million in 2023, then gained by 28.96% to $142.4 million in 2024, then gained by 14.5% to $163.1 million in 2025, then advanced by 11.31% to $181.5 million in 2026.
- Business Quant data shows NUVL's Change in Acquisitions & Divestments at $181.5 million in Q1 2026, $163.1 million in Q4 2025, and $232.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 181.55 Mn |
| Mar 31, 2026 | 181.55 Mn |
| Dec 31, 2025 | 163.10 Mn |
| Dec 31, 2025 | 163.10 Mn |
| Sep 30, 2025 | 232.44 Mn |
| Sep 30, 2025 | 232.44 Mn |
| Jun 30, 2025 | 235.55 Mn |
| Jun 30, 2025 | 235.55 Mn |
| Mar 31, 2025 | 302.59 Mn |
| Mar 31, 2025 | 302.59 Mn |
| Dec 31, 2024 | 142.45 Mn |
| Dec 31, 2024 | 142.45 Mn |
| Sep 30, 2024 | 127.71 Mn |
| Sep 30, 2024 | 127.71 Mn |
| Jun 30, 2024 | 105.04 Mn |
| Jun 30, 2024 | 105.04 Mn |
| Mar 31, 2024 | 76.25 Mn |
| Mar 31, 2024 | 76.25 Mn |
| Dec 31, 2023 | 110.46 Mn |
| Dec 31, 2023 | 110.46 Mn |